Now, we could show in the AXSANA study very clearly with a large patient cohort that the sensitivity, accuracy of sentinel lymph node biopsy as well as TAD is independent from tumor subtypes. The more widely discussed question is whether patients can undergo less invasive procedures, less invasive staging procedures, even if they have higher nodal burden at presentation. So far, most surgeons performed sentinel lymph node biopsy or TAD in patients who had up to three clinically involved lymph nodes...
Now, we could show in the AXSANA study very clearly with a large patient cohort that the sensitivity, accuracy of sentinel lymph node biopsy as well as TAD is independent from tumor subtypes. The more widely discussed question is whether patients can undergo less invasive procedures, less invasive staging procedures, even if they have higher nodal burden at presentation. So far, most surgeons performed sentinel lymph node biopsy or TAD in patients who had up to three clinically involved lymph nodes. The AXSANA study very clearly showed that recurrence rates are not increased even in patients with four, five, six, or even more nodes. Interestingly, and these data have been presented at the ASCO meeting this year, nodal PCR rates were independent from initial nodal burden. They exclusively depended on tumor biology. So patients with one to three initially POSITIVE lymph nodes compared to those with more than three suspicious lymph nodes had the same nodal CONVERSION rate and the CONVERSION only depended on subtypes. So, therefore, we concluded and we modified German guidelines and most international guidelines have been modified so far that patients with all nodal stages can undergo less invasive procedures to stage the axilla if they are not POSITIVE in the beginning and then CONVERT to node negativity. And the question whether it’s TAD or sentinel lymph node biopsy, there’s still some advantage for TAD we would say, probably, but many surgeons throughout the world also favor sentinel-lymph node biopsies. There’s certainly a cost problem for Tad which is more cost intensive because you need a marker or you need a seed. On the other hand, data that we have PREFER targeted axillary section as a precise procedure which, by the way, leads to the removal of less lymph nodes compared to sentinel lymph node biopsy. So in AXSANA and other studies, we could show that the average number of removed lymph nodes for TAD is four compared to three for sentinel-lymph node biopsies. So TAD is more targeted and removes less lymph node.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.